Skip to main content

Table 1 Demographic and clinical characteristics of all subjects

From: Different resting-state network disruptions in newly diagnosed drug-naïve Parkinson’s disease patients with mild cognitive impairment

Parameter

PD, all

HC

PD-CU

PD-MCI

P1

P2

P3

Number, n

47

28

19

28

Handedness of writing (R: L)

47: 0

28: 0

19: 0

28:0

Age, y

55.00 ± 9.27

52.06 ± 7.00

54.88 ± 10.89

55.07 ± 8.20

0.085#

0.361

0.947#

Gender, M/F

23/24

8/20

8/11

15/13

0.083

0.164

0.440

Duration of disease, years

1.74 ± 1.61

1.87 ± 1.32

1.65 ± 1.80

0.288#

H & Y stage

1.87 ± 0.37

1.82 ± 0.58

1.000#

UPDRS score

Part I

0.79 ± 1.72

0.86 ± 1.21

0.448#

Part II

6.63 ± 3.18

6.21 ± 4.09

0.710

Part III

20.79 ± 7.44

19.79 ± 8.71

0.683

Part IV

0

0

NMSS score

  

21.95 ± 20.82

25.96 ± 21.73

  

0.380#

HDRS score

5.21 ± 6.87

6.79 ± 5.32

0.112#

HARS score

3.79 ± 4.88

5.68 ± 4.30

0.058#

MoCA score

27.89 ± 2.49

24.89 ± 3.28

0.002*

EDU, years

10.04 ± 4.01

10.29 ± 3.75

12.53 ± 3.03

8.36 ± 3.74

0.757#

0.001*

< 0.001*#

  1. *Indicates significant difference;
  2. # Indicates the nonparametric test because of the non-normal distribution;
  3. 1 Comparison between all PD patients (PD-MCI and PD-CU) and HCs
  4. 2 Comparison among PD-MCI, PD-CU patients, and HCs
  5. 3 Comparison between PD-CU and PD-MCI patients
  6. Keys: PD Parkinson’s disease; HC healthy control; PD-CU PD patients with cognitive unimpaired; PD-MCI PD patients with mild cognitive impaired; R right; L left; M male; F female; H & Y Hoehn & Yahr; UPDRS unified PD rating scale; NMS non-motor symptoms; HDRS Hamilton depression rating scale; HARS Hamilton anxiety rating scale; MoCA Montreal cognitive assessment; EDU education